These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8927235)

  • 41. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolonged pulsatile administration of ovine corticotropin-releasing hormone in normal man.
    Désir D; Van Cauter E; Beyloos M; Bosson D; Golstein J; Copinschi G
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1292-9. PubMed ID: 3023419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects.
    Rittmaster RS; Cutler GB; Sobel DO; Goldstein DS; Koppelman MC; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1985 May; 60(5):891-5. PubMed ID: 2984235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration.
    DeBold CR; Sheldon WR; DeCherney GS; Jackson RV; Nicholson WE; Island DP; Orth DN
    J Clin Endocrinol Metab; 1985 May; 60(5):836-40. PubMed ID: 2984233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potentiation of peptide histidine methionine (PHM) on corticotropin-releasing hormone (CRH) induced ACTH secretion in humans.
    Sasaki A; Sato S; Go M; Murakami O; Hanew K; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1305-7. PubMed ID: 2824555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Indomethacin and meclofenamate do not alter ACTH and cortisol responses to corticotropin-releasing hormone (CRH) in normal subjects.
    Zacharieva S; Wippermann M; Muchá I; Andonova K; Jankova G
    Clin Physiol Biochem; 1993; 10(1):28-32. PubMed ID: 8393395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone, in Cushing's disease.
    Cannavò S; Ambrosi B; Chiodini I; Vigo T; Russo A; Milici C; Barbetta L; Dall'Asta C; Adda G; Arosio M
    J Endocrinol Invest; 2004 May; 27(5):RC8-11. PubMed ID: 15279069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Corticotropin-releasing hormone: stimulation of ACTH secretion in normal man.
    DeBold C; Orth DN; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Island DP
    Horm Metab Res Suppl; 1987; 16():8-16. PubMed ID: 2832299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of a specific effect of corticotropin-releasing hormone (CRH) on plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in normal subjects.
    Zacharieva S; Muchá I; Wippermann M; Sheitanova S; Andonova K
    Prostaglandins Leukot Essent Fatty Acids; 1995 Jan; 52(1):55-7. PubMed ID: 7708821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion.
    Kalogeras KT; Nieman LK; Friedman TC; Doppman JL; Cutler GB; Chrousos GP; Wilder RL; Gold PW; Yanovski JA
    J Clin Invest; 1996 May; 97(9):2045-50. PubMed ID: 8621793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ovine corticotropin-releasing hormone stimulation test in normal children.
    Ross JL; Schulte HM; Gallucci WT; Cutler GB; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1986 Feb; 62(2):390-2. PubMed ID: 3001126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of corticotropin-releasing hormone on ACTH, cortisol and 13, 14-dihydro-15-keto prostaglandin E2 in patients with diabetes insipidus before and after captopril treatment.
    Zacharieva S; Andreeva M; Orbetzova M; Wippermann M; Mucha I; Andonova K; Sheitanova S
    Prostaglandins Leukot Essent Fatty Acids; 1996 Jun; 54(6):433-7. PubMed ID: 8888355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
    Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans.
    Sasaki A; Shinkawa O; Yoshinaga K
    J Clin Invest; 1989 Dec; 84(6):1997-2001. PubMed ID: 2556451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of L-NAME, a specific nitric oxide synthase inhibitor, on corticotropin-releasing hormone-elicited ACTH and corticosterone secretion.
    Bugajski J; Borycz J; Gadek-Michalska A; Głód R
    J Physiol Pharmacol; 1998 Dec; 49(4):607-16. PubMed ID: 10069701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of hypophysectomy on corticotropin-releasing hormone and adrenocorticotropin immunoreactivities in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Markowska A; Nussdorfer GG
    Mol Cell Neurosci; 1994 Aug; 5(4):345-9. PubMed ID: 7804604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.